In another study, treating cancer stem cells (CSC) derived from the LN18 GBM cell line with ATRA, inhibited the expression of Nestin and induced cell differentiation through the activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) [20]. Here, MAPK3 is linked to cancer.